News
Do you want news from Flemingsberg directly to your inbox? Subscribe to our newsletter. Register here.
Check out the newsletter archive here.
Stockholm Life Tech gets full funding
Stockholm Life Tech is awarded over SEK 16 million from the European Regional Development Fund. The project is run by Region Stockholm and will enable advanced development and production environments in Flemingsberg to be opened to small and medium-sized companies. In Flemingsberg, it is primarily ANA Futura and Vecura that are opened to more small and medium-sized companies working on advanced therapies. Something that can support the growth of small and medium-sized companies in life science.
A strategy, a plan, but above all, action!
The Flemingsberg Science Foundation board approved its business plan for 2022 in January. This essentially paves the way for an increase in the pace of business set-ups and opportunities to innovate in Flemingsberg. Almost six months on, what have we achieved?
Ten-year-old XNK Therapeutics experiences rapid growing with own GMP facility
XNK Therapeutics has expanded significantly in the past year and now has access to its own GMP-standard production lab.
Hela wins Flemingsberg Science Award
Hela is a company that is developing a mobile application that helps people with heart conditions improve their cardiac rehabilitation. The app encourages daily exercise, provides care support, and the ability to monitor progress.
Restart for Tullinge work hub
Just before the pandemic, a research project was initiated in Tullinge in which residents were offered a place at a local work hub as an alternative to commuting to work. The hub is now seeing something of a reopening in a project aimed at increasing shared use and resource efficiency.
Successful Kodkupan Flemingsberg pilot
During the Kodkupan award evening in Flemingsberg, parents got to see the results of middle school students’ programming projects. Games and animations from the project were shown, prompting laughter and applause.
Martin Jönsson: “The time is ripe for a breakthrough in dementia treatment”
Nearly 100,000 people in Sweden suffer from Alzheimer’s. Globally, about 30 million people are thought to have the disease. There is still no cure, but research is approaching a point where new drugs may become crucial. AlzeCure is one of the pharmaceutical companies that has made the most progress.
What´s on Instagram?
Tittar man upp så kan man se så mycket som en gyllene Mona Lisa av Sam Westerholm här på campusflemingsberg 🌞😊👋
#ArtemisKI #Artemis #Karolinska #karolinskainstitutet #campusflemingsberg #medicinskaföreningen #sverigesarbetsterapeutstudenter #kistudents #studyinsweden #monalisa
Thank you, Sanji Chandramohan and Laurence Karsent from Thor Equities for coming and visiting us and for giving us the opportunity to show you our campus and tell you about the future development in Flemingsberg. #campusflemingsberg #flemingsbergscience #flemingsberg #thorequities
Thank you, Sanji Chandramohan and Laurence Karsent from Thor Equities for coming and visiting us and for giving us the opportunity to show you our campus and tell you about the future development in Flemingsberg. #campusflemingsberg #flemingsbergscience #flemingsberg #thorequities
Vi startade morgonen med lite omvärldsbevakning genom att delta i @sthlmscicity frukostseminarium Hagastaden - a great place for Life Science. Bra presentationer och diskussioner kring utvecklingen av Life Science kluster och vilka möjligheter det skapar för andra företag och organisationer som vill etablera sig nära akademier och sjukhus. #hagastaden #omvärldsbevakning #flemingsberg #campusflemingsberg #lifescience #kluster
Read the newsletter
Keep up with the latest news, updates and insights on our work. We also cover infrastructure development in Flemingsberg. Subscribe to our newsletter. Sign up here!
Newsletter archive
Below older issues of the newsletter.
